To achieve long-term capital growth while maintaining an adequate spread of risk.
Name | % Net Assets |
---|---|
Vodafone Group | 6.6% |
HSBC Holdings | 5.9% |
BP | 5.5% |
GlaxoSmithKline | 5.2% |
Royal Bank of Scotland Group | 5.1% |
Shell Transport & Trading | 3.4% |
HBOS | 3.4% |
Barclays | 3.3% |
mmO2 | 2.0% |
AstraZeneca | 2.0% |
Key | % Net Assets |
---|---|
Vodafone Group | 6.6% |
HSBC Holdings | 5.9% |
BP | 5.5% |
GlaxoSmithKline | 5.2% |
Other | 76.8% |
Date | 24-Feb-2017 |
---|---|
NAV | 1,417.00p |
Currency | GBP |
Change | -1,251.81p |
% | -99.27% |
YTD change | 1,417.00p |
YTD % | n/a |
Fund Inception | 03/07/2000 |
---|---|
Fund Manager | Morgan Stanley Investment Mgt Ltd |
TER | - |
Minimum Investment | |
---|---|
Initial | £250000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 0.80% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.05 |
You are here: research